You are here

Remicade

FDA approves Celltrion’s subcutaneous Remicade biosimilar for IBD

Pharm

Mon, 10/23/23 - 05:20 pm

ulcerative colitis

Crohn's Disease

J&J finalizes $25M settlement, laying Remicade antitrust allegations to rest

Endpoints

Mon, 03/20/23 - 09:50 am

J&J, BMS arthritis drugs lowered death risk among COVID patients in federal study

Fierce Pharma

Thu, 06/2/22 - 07:29 pm

Bristol Myers Squibb

rheumatoid arthritis

clinical trials

Pfizer, Johnson & Johnson settle high-profile Remicade biosim lawsuit on undisclosed terms

Fierce Pharma

Mon, 07/26/21 - 10:14 pm

Pfizer's Unheralded Franchise That's Worth Billions of Dollars

Motley Fool

Sun, 08/16/20 - 10:44 pm

autoimmune disease

J&J offered doctors free services and profit-making advice to boost Remicade scripts: whistleblower suit

Fierce Pharma

Wed, 02/19/20 - 11:40 pm

whistleblower lawsuits

J&J's Remicade losing ground in Quebec health plan despite court victory

Yahoo/Reuters

Wed, 11/13/19 - 09:59 am

autoimmune disease

Celltrion taps Lonza to produce some of its Remicade biosimilar

Biopharma Dive

Thu, 09/5/19 - 08:19 pm

FTC Issues Civil Investigative Demand to Johnson & Johnson Regarding Remicade

Big Molecule Watch

Sun, 08/25/19 - 05:02 pm

FTC investigates J&J contracts regarding the drugmaker's blockbuster Remicade

Endpoints

Tue, 07/30/19 - 07:59 am

6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals

Motley Fool

Sat, 05/18/19 - 08:42 pm

consumer health

immuno-oncology

UnitedHealthcare gives Remicade biosims a leg up with changes to Medicare plans

Fierce Pharma

Mon, 10/15/18 - 11:30 pm

UnitedHealthcare

Pfizer lawsuit could clear path for biosimilars

Medical Marketing and Media

Fri, 08/24/18 - 10:36 pm

Judge Denies J&J Motion to Dismiss Pfizer Lawsuit Over Remicade

RAPS.org

Mon, 08/13/18 - 09:43 am

Pfizer Wins Remicade Patent Case Over J&J

RAPS.org

Wed, 08/1/18 - 11:33 pm

Amgen Announces Top-Line Data From Remicade Biosimilar Study

Yahoo/Zacks.com

Thu, 06/28/18 - 09:34 am

rheumatoid arthritis

Novartis touts effectiveness, safety of autoimmune drug copies

Yahoo/Reuters

Fri, 06/15/18 - 09:57 am

autoimmune disease

Can Johnson & Johnson Replace Remicade for $100 Million Upfront?

Motley Fool

Wed, 02/21/18 - 09:40 am

inflammatory bowel disease

Remicade biosims from Pfizer, Merck unlikely to turn the tide in 2018: analyst

Fierce Pharma

Fri, 02/16/18 - 09:29 pm

Biosimilars Council Sides with Pfizer in Antitrust Dispute with J&J

JD Supra

Tue, 02/6/18 - 08:40 pm

Pages